Latest News

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.

Two women found friendship and solidarity as they go about their lives after a glioblastoma diagnosis.

Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.

As home to the state's only neuro-oncologists, MUSC Hollings Cancer Center can offer the latest care options and clinical trials to people with brain tumors.

The Engevik sisters live for science – and they get to do it together at MUSC.

Dr. Jennifer Dahne's focus on making behavioral health interventions accessible to more people has been recognized with a governor's award.

LOWVELO funds are enabling Leonardo Ferreira, Ph.D., to pursue his ideas to bring cellular therapy to solid tumors for cancer treatment.

A simple test to learn about his ancestry uncovered an unexpected syndrome that increases the risk of cancer.

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

15 years after a terminal diagnosis, Nathan Calhoun is alive thanks to a clinical trial. It's why he performed at LOWVELO in 2024.